Company Filing History:
6 out of 2,405 
2 out of 63 
Years Active: 2010-2013
Title: Georgia B McGaughey: Innovator in Neurological and Psychiatric Treatments
Introduction
Georgia B McGaughey is a prominent inventor based in Harleysville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological and psychiatric disorders. With a total of 6 patents to her name, her work has the potential to impact many lives.
Latest Patents
One of her latest patents is focused on bridged diazepan orexin receptor antagonists. This invention is directed to bridged diazepan compounds that act as antagonists of orexin receptors. These compounds are useful in the treatment or prevention of neurological and psychiatric disorders where orexin receptors play a crucial role. Additionally, the invention includes pharmaceutical compositions comprising these compounds and their application in treating such diseases.
Another significant patent involves tertiary carbinamines with substituted heterocycles, which serve as beta-secretase inhibitors for the treatment of Alzheimer's disease. This invention targets tertiary carbinamine compounds that inhibit the beta-secretase enzyme, which is involved in diseases like Alzheimer's. The patent also covers pharmaceutical compositions that utilize these compounds for effective treatment.
Career Highlights
Georgia has worked with notable companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Sunesis Pharmaceuticals, Inc. Her experience in these organizations has contributed to her expertise and innovative capabilities in drug development.
Collaborations
Throughout her career, Georgia has collaborated with esteemed colleagues such as Shaun R Stauffer and Philippe G Nantermet. These partnerships have likely enhanced her research and development efforts, leading to her successful inventions.
Conclusion
Georgia B McGaughey is a trailblazer in the pharmaceutical field, with a focus on developing innovative treatments for neurological and psychiatric disorders. Her contributions through her patents and collaborations highlight her commitment to improving healthcare outcomes.